Larvol Delta - Arch-Biopartners-Submits-Application-to-Health-Canada-to-Conduct-COVID19-Phase-II-Human-Trial-for-Metablok-to-Prevent-Lung-and-Kidney-Inflammation

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2020/04/23/2021346/0/en/Arch-Biopartners-Submits-Application-to-Health-Canada-to-Conduct-COVID19-Phase-II-Human-Trial-for-Metablok-to-Prevent-Lung-and-Kidney-Inflammation.html

Apr 23, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next